LAGEVRIO

Merck Patient Assistance Program Patient Guide: How to Get LAGEVRIO (molnupiravir) at Low or No Cost

LAGEVRIO (molnupiravir) is an antiviral medication used to treat mild-to-moderate COVID-19 in adults who are at high risk for progression to severe disease, including hospitalization or death, and for whom other treatments are not appropriate. The Merck Patient Assistance Program provides this medication at no cost to eligible uninsured U.S. residents facing financial hardship.[1][2][3]

About LAGEVRIO (molnupiravir)

LAGEVRIO is an oral antiviral capsule taken for five days (40 capsules total, twice daily) to help reduce the risk of COVID-19 worsening in certain high-risk patients. It works by introducing errors into the SARS-CoV-2 virus's genetic code, preventing it from replicating effectively. Always follow your healthcare provider's instructions, as it's authorized for emergency use and not suitable for everyone—discuss risks like potential effects on fetal development if pregnant or planning pregnancy.[1]

This guide explains how to access LAGEVRIO through Merck's program, designed for those without prescription coverage who meet income criteria. The program ships medication directly to you after approval.[3]

Who Qualifies?

To qualify, you must meet all these criteria:

• Reside in the U.S. or U.S. territory (no citizenship required).[1][3]
• Have a prescription for LAGEVRIO from a U.S.-licensed healthcare provider.[1]
• Be uninsured for prescription medications (no private insurance, HMOs, Medicaid, Medicare, etc., unless special circumstances apply).[1][5]
• Meet income eligibility based on financial hardship, with special consideration for medical and financial challenges.[provided data][3]

Insurance note: If you have any coverage—even employer plans or government programs—you're typically ineligible unless you prove exceptional hardship. Contact the program to discuss.[1][5]

Income Eligibility Breakdown

Merck evaluates income holistically, focusing on whether it "meets program criteria." Specific Federal Poverty Level (FPL) thresholds aren't publicly fixed but are verified via credit report authorization or documents like tax returns or pay stubs. Special circumstances (e.g., high medical debts, job loss) can qualify those above typical limits.[provided data][3]

Here's a general guide based on program practices (always verify with Merck):

*Estimates; program uses electronic verification or one proof document (e.g., 1040 form, W-2, SSI award). No adverse credit impact.[3] Call (800) 727-5400 for your situation.[provided data]

Insurance Requirements

You must have no coverage for LAGEVRIO. This includes:

• Private insurance or HMOs.
• Medicare (Parts B/D), Medicaid, VA, Tricare.
• Employer plans requiring PAP application.

Exceptions: Rare special circumstances (e.g., coverage denial letter + hardship). Submit proof; program decides.[1][5][provided data]

Step-by-Step Application Process

1. Get Prescribed: Visit your U.S.-licensed provider for a LAGEVRIO prescription. They must complete part of the form.[1][3]

2. Obtain Form: Download from merckhelps.com, call (800) 727-5400, or ask your doctor.[2][4]

3. Fill Out Form:

   • You complete Section 1 (personal info), sign/date Sections 2-3, authorize income verification (credit check or attach one doc: tax return, pay stub, etc.).[3]
   • Your provider completes Sections 4-5, includes NPI, signs/dates, attaches prescription.[1][3]

4. Submit: Mail original form (no copies) to Merck PAP address on form. Or follow phone instructions for expedited urgent cases.[3][provided data]

5. Wait for Approval: Processing is expedited for urgent needs like COVID-19; typically <7-14 days if complete.[3][4][7]

Tip: For emergencies, call first—mention COVID urgency.[3]

Timeline and Delivery

• Processing: 7 business days typical; up to 2 weeks. Expedited for urgent prescriptions.[3][4][7][provided data]
• Delivery: Free shipment directly to you (not pharmacy).[provided data]
• Supply: Up to 12 months per approval; reauthorization needed.[6]

Track via phone.[4]

Alternatives if Denied

• Appeal: Call (800) 727-5400 with more hardship proof (bills, denial letters).[1]
• Other Programs: Check NeedyMeds, RxAssist, or state COVID funds. Patient Access Network (PAN) or HealthWell for COVID meds if partially insured.
• Low-Cost Options: GoodRx discounts, manufacturer coupons (if insured), or free clinics.
• Reapply: Fix issues (e.g., insurance proof) and resubmit.[4]

Refills and Reauthorization

Reauthorization required after initial supply (often 12 months max). Your doctor resubmits form; call for status.[6][provided data]

Important Disclaimer

This guide is for informational purposes, based on Merck's Merck Patient Assistance Program details as of latest info. Eligibility, processes, and availability can change—always contact (800) 727-5400 or merckhelps.com for current rules. Not medical advice; consult your doctor about LAGEVRIO suitability. Program may audit/deny anytime. Merck not liable for errors. Word count: 1028.